PATENT CLAIM ANALYSIS

Application Number: 15872776
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "401000"]

Abstract:
The invention provides compounds of formula Ia′, Ib′, Ic′, and Id′: and pharmaceutically acceptable salts thereof, wherein the variables A, R 6 , R 7 , R 8 , R 9 , R x , L, X, Y, and Z have the meaning as described herein. The compounds are useful for reducing endoplasmic reticulum stress and for producing analgesia in an animal.

Claim (Index 13):
The method of  claim 12  wherein the compound of formula Ia\u2032, Ib\u2032 Ic\u2032, or Id\u2032, or a pharmaceutically acceptable salt thereof is E-guanabenz or Z-guanabenz, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.4898
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15257926', '16322945', '14576890', '15577771', '14927501']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7659851904923446
- 35 USC 102 Novelty (BERT): 0.5399764064312063
- Combined Prediction Score: 0.7433843120862308
- Mean Citation Score: 363.259876
- Max Citation Score: 370.81226
- Similarity Product: 254.8149171126628

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test